Matthew Winton

Business address
C/O Inozyme Pharma, Inc., 321 Summer Street, Suite 400, Boston, MA, 02210
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Matthew Winton has filed 13 SEC EDGAR filings since 4/4/2023

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 Nov 19, 2025 Nov 17, 2025 001-37942
4 Open Document Open Filing FORM 4 Nov 17, 2025 Nov 14, 2025 001-37942
4 Open Document Open Filing FORM 4 Oct 8, 2025 Oct 6, 2025 001-37942
3 Open Document Open Filing FORM 3 Oct 8, 2025 Oct 6, 2025 001-37942
4 Open Document Open Filing 4 Jul 3, 2025 Jul 1, 2025 001-39397
4 Open Document Open Filing 4 Jun 27, 2025 Jun 25, 2025 001-39397
4 Open Document Open Filing 4 Apr 2, 2025 Mar 31, 2025 001-39397
4 Open Document Open Filing 4 Mar 17, 2025 Mar 11, 2025 001-39397
4 Open Document Open Filing 4 Oct 3, 2024 Sep 30, 2024 001-39397
4 Open Document Open Filing 4 Apr 3, 2024 Mar 28, 2024 001-39397
4 Open Document Open Filing 4 Mar 15, 2024 Mar 13, 2024 001-39397
4 Open Document Open Filing FORM 4 SUBMISSION Apr 4, 2023 Apr 3, 2023 001-39397
3 Open Document Open Filing FORM 3 SUBMISSION Apr 4, 2023 Apr 3, 2023 001-39397